Form 4: Blend Labs Head of Revenue Sells 20,000 Shares Under Pre-Arranged Plan

Blend Labs, Inc.'s Head of Revenue, Brian Kneafsey, sold 20,000 shares of Class A Common Stock for a weighted average price of $3.312 per share on June 30, 2025, pursuant to a Rule 10b5-1 trading plan.

Summary

• Brian Kneafsey, the Head of Revenue at Blend Labs, Inc. (BLND), reported a transaction involving the company's Class A Common Stock.
• On June 30, 2025, Mr. Kneafsey disposed of 20,000 shares of Class A Common Stock.
• The shares were sold at a weighted average price of $3.312 per share, with individual sale prices ranging from $3.30 to $3.34.
• Following this transaction, Brian Kneafsey beneficially owns 786,598 shares of Class A Common Stock.
• The sale was executed under a Rule 10b5-1 trading plan, which was adopted by Mr. Kneafsey on March 14, 2025.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While insider selling can be perceived negatively, the execution under a Rule 10b5-1 plan mitigates concerns about the sale being based on new, undisclosed negative information, suggesting a planned liquidity or diversification event.

Positives

• The sale was conducted under a pre-arranged Rule 10b5-1 trading plan, indicating a planned liquidity event rather than a reaction to new, negative material non-public information.

Negatives

• The sale by a high-ranking executive reduces their direct ownership stake in the company, which can sometimes be perceived negatively by investors.

Risks

• Insider selling, even when pre-planned, can sometimes be misinterpreted by the market as a lack of confidence, potentially leading to negative short-term stock price movements.

Future Outlook

Not applicable as this document is a report of an insider transaction and does not contain forward-looking statements or guidance.

Industry Context

This filing reports a routine insider transaction and does not provide information directly related to broader industry trends or competitive dynamics.

Stakeholder Impact

• Shareholders: May view the reduction in executive ownership with caution, though the 10b5-1 plan provides transparency and suggests a pre-planned action rather than a reaction to new information.

Key Dates

Keywords

Blend Labs, BLND, Form 4, insider trading, stock sale, Brian Kneafsey, Head of Revenue, 10b5-1 plan, equity securities